Efficacy of Omega-3 Fatty Acids on Borderline Personality Disorder

NCT00437099 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Borderline Personality Disorder.

Interventions

DRUG: Omacor®
DRUG: Placebo

Sponsor

Hospital Universitari Vall d'Hebron Research Institute